Measures of postprandial lipoprotein metabolism do not predict the presence of coronary artery disease in patients with type 2 diabetes mellitus

被引：0
|
作者：
Tuck, C
Chen, NT
Torres, M
Sanchez, M
Holleran, S
Ramakrishnan, R
Berglund, L
Ginsberg, H
机构：
来源：
DIABETES | 2000年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
56
引用
收藏
页码：A14 / A14
页数：1
相关论文
共 50 条
  • [1] Measures of postprandial lipoproteins are not associated with coronary artery disease in patients with type 2 diabetes mellitus
    Reyes-Soffer, Gissette
    Holleran, Steve
    Karmally, Wahida
    Ngai, Colleen I.
    Chen, Niem-Tzu
    Torres, Margarita
    Ramakrishnan, Rajasekhar
    Blaner, William S.
    Berglund, Lars
    Ginsberg, Henry N.
    Tuck, Catherine
    [J]. JOURNAL OF LIPID RESEARCH, 2009, 50 (09) : 1901 - 1909
  • [2] Elevated lipoprotein (a) levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus
    Zhang, H-W
    Zhao, X.
    Guo, Y-L
    Gao, Y.
    Zhu, C-G
    Wu, N-Q
    Li, J. J.
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2018, 28 (10) : 980 - 986
  • [3] THE ROLE OF LIPOPROTEIN METABOLISM AND INFLAMMATORY GENE POLYMORPHIMS ON THE CORONARY ARTERY DISEASE WITH TYPE 2 DIABETES MELLITUS
    Coban, N.
    Ozuynuk, A. S.
    Erkan, A. F.
    Ekici, B.
    Vurgun, E.
    Erginel-unaltuna, N.
    Diker, I. Y.
    [J]. ATHEROSCLEROSIS, 2018, 275 : E112 - E113
  • [4] POSTPRANDIAL LIPOPROTEIN METABOLISM IN TYPE-2 DIABETES-MELLITUS
    TAN, KCB
    COOPER, MB
    LING, KLE
    GRIFFIN, B
    SHEPHERD, J
    PACKARD, C
    BETTERIDGE, DJ
    [J]. DIABETOLOGIA, 1992, 35 : A168 - A168
  • [5] Cholesterol absorption and lipoprotein metabolism in type II diabetes mellitus with and without coronary artery disease
    Gylling, H
    Miettinen, TA
    [J]. ATHEROSCLEROSIS, 1996, 126 (02) : 325 - 332
  • [6] Silent coronary artery disease in patients with type 2 diabetes mellitus
    Gokcel, A
    Aydin, M
    Yalcin, F
    Yapar, AF
    Ertorer, ME
    Ozsahin, AK
    Muderrisoglu, H
    Aktas, A
    Guvener, N
    Akbaba, M
    [J]. ACTA DIABETOLOGICA, 2003, 40 (04) : 176 - 180
  • [7] Management of coronary artery disease in patients with type 2 diabetes mellitus
    Srikanth S.
    Deedwania P.
    [J]. Current Cardiology Reports, 2007, 9 (4) : 264 - 271
  • [8] Silent coronary artery disease in patients with type 2 diabetes mellitus
    A. Gokcel
    M. Aydin
    F. Yalcin
    A. F. Yapar
    M. E. Ertorer
    A. K. Ozsahin
    H. Muderrisoglu
    A. Aktas
    N. Guvener
    M. Akbaba
    [J]. Acta Diabetologica, 2003, 40 : 176 - 180
  • [9] Effects of miglitol versus sitagliptin on postprandial glucose and lipoprotein metabolism in patients with type 2 diabetes mellitus
    Okada, Kenta
    Yagyu, Hiroaki
    Kotani, Kazuhiko
    Yamazaki, Hisataka
    Ozaki, Kazufumi
    Takahashi, Manabu
    Nagashima, Shuichi
    Osuga, Jun-ichi
    Ishibashi, Shun
    [J]. ENDOCRINE JOURNAL, 2013, 60 (07) : 913 - 922
  • [10] Lipoprotein(a) as a Higher Residual Risk for Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus than without
    Yu, Bingyan
    Hu, Xiangming
    Liu, Jieliang
    Nie, Zhiqiang
    Bu, Ci Ren Luo
    Li, Guang
    Zhou, Yingling
    Dong, Haojian
    [J]. INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 3383 - 3391
12345